Press release
Investigation announced for Long-Term Investors in shares of Altimmune, Inc. (NASDAQ: ALT) over potential Wrongdoing
An investigation on behalf of current long term investors in Altimmune, Inc. (NASDAQ: ALT) shares.
Investors who are current long term investors in Altimmune, Inc. (NASDAQ: ALT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ALT stocks follows a lawsuit filed against Altimmune, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ALT stocks, concerns whether certain Altimmune, Inc. (directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of Maryland the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Altimmune overstated the potential for pemvidutide to stand out from competing GLP-1 agonists based on the drug's efficacy and tolerability results observed in the MOMENTUM Trial, that accordingly, the MOMENTUM Trial results were less significant to pemvidutide's clinical, commercial, and competitive prospects than Defendants had led investors to believe, that as a result of all the foregoing, Defendants had overstated Altimmune's prospects for finding a strategic partner to develop pemvidutide, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Altimmune, Inc. (NASDAQ: ALT) over potential Wrongdoing here
News-ID: 3867995 • Views: …
More Releases from Shareholders Foundation, Inc.
Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) Long Term should c …
An investigation was announced for current long-term investors in shares of BioAge Labs, Inc. (NASDAQ: BIOA) concerning potential breaches of fiduciary duties by certain directors of BioAge Labs, Inc.
Investors who are current long term investors in BioAge Labs, Inc. (NASDAQ: BIOA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
e.l.f. Beauty, Inc. (NYSE: ELF) Investor Notice: Deadline in Lawsuit on May 5, 2 …
A deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of e.l.f. Beauty, Inc. (NYSE: ELF).
Investors who purchased shares of e.l.f. Beauty, Inc. (NYSE: ELF) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. e.l.f. Beauty, Inc. (NYSE: ELF) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed…
Investigation announced for Long-Term Investors in Revance Therapeutics, Inc. (N …
An investigation was announced for current long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors of Revance Therapeutics, Inc.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Skyworks Solutions, Inc. (NASDAQ: SWKS) Shareholder Notice: Deadline in Lawsuit …
The Shareholders Foundation announced that a deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of Skyworks Solutions, Inc. (NASDAQ: SWKS) over alleged securities laws violations by Skyworks Solutions, Inc.
Investors who purchased shares of Skyworks Solutions, Inc. (NASDAQ: SWKS) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. Skyworks Solutions, Inc. (NASDAQ: SWKS) stockholders should contact the Shareholders…
More Releases for Altimmune
Adenovirus Vector Vaccine Market to Witness Huge Growth by Key Players: Johnson …
The study provides an in-depth analysis of the major market players in the Adenovirus Vector Vaccine market. It provides a detailed analysis of each segment and driving factors coupled with growth rate analysis. Furthermore, the report also provides regional analysis that offers insights on the market potential across each region to enable market players to leverage market opportunities. The Adenovirus Vector Vaccine research report provides region-wise and country-wise market scope…
Typhoid Vaccines Market to see Huge Growth by 2025 | Altimmune, Bavarian Nordic …
A new business intelligence report released by HTF MI with title "Global Typhoid Vaccines Market Report 2019 - Market Size, Share, Price, Trend and Forecast" is designed covering micro level of analysis by manufacturers and key business segments. The Global Typhoid Vaccines Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and…
Biodefense Market Prominent Players - Achaogen, Alnylam Pharmaceuticals, Altimmu …
Biodefense Market to exceed USD 17 billion by 2024 as per a new research report.
Growing bioterrorism and research for early development of medical countermeasures against chemical threats will drive biodefense market over the forecast timeframe. Increasing use of bio-agents coupled with rising need of biosecurity should fuel the industry growth. Increasing threats of radiation exposure, infectious diseases and chemicals coupled with lethal pathogens, such as avian influenza will stimulate global…
Hepatitis Drug Development Pipeline Review 2018 - Abivax, AiCuris, AIMM Therapeu …
Hepatitis Drug Development Pipeline Review, 2018
Summary
This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, hepatitis B, hepatitis D and hepatitis E, and features dormant and discontinued products.
Hepatitis refers to inflammation of the liver and is most commonly caused by viral infections. Hepatitis A and E are typically caused…
Bioterrorism Market to Witness Huge Growth by 2025: Key Players - Altimmune, Bav …
HTF MI recently introduced Global Bioterrorism Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC), Emergent BioSolutions, Acambis, Achaogen, Cleveland…
Biodefense Global Market Top Key Players – Altimmune, Bavarian Nordic, DynPort …
Biodefense Market 2017
Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological…
